Welcome to Dwaey, specifically on Streptokinase page.
This medicine contains important and useful components, as it consists of
Streptokinase is available in the market in concentration.
Streptokinase
Before using Streptokinase, it is essential to consult your healthcare provider to ensure it is safe and appropriate for you. Several precautions should be considered:
- Allergy: Streptokinase is derived from streptococcal bacteria. Patients with a history of streptococcal infections or allergic reactions to streptococci should avoid this drug. An allergic reaction could include symptoms such as rash, swelling, or difficulty breathing.
- Recent Surgery or Trauma: Streptokinase can increase the risk of bleeding. Patients who have recently undergone surgery, experienced trauma, or have internal bleeding should use caution when receiving this medication.
- History of Stroke or Brain Hemorrhage: Streptokinase should not be used in individuals with a history of stroke, particularly if it was due to bleeding (hemorrhagic stroke).
- Active Bleeding: Streptokinase is contraindicated in patients with active bleeding, including gastrointestinal bleeding, intracranial hemorrhage, or bleeding disorders such as hemophilia.
- Pregnancy and Lactation: The safety of Streptokinase during pregnancy has not been well established. It should only be used in pregnancy if absolutely necessary and if the potential benefits outweigh the risks. Streptokinase may pass into breast milk, so caution is advised if used during breastfeeding.
- Renal Impairment: Streptokinase should be used cautiously in patients with renal impairment, as it may exacerbate bleeding risks.
Streptokinase is a thrombolytic agent used to dissolve blood clots in a variety of acute conditions. Its primary indications include:
- Acute Myocardial Infarction (MI): Streptokinase is commonly used to treat acute ST-elevation myocardial infarction (STEMI) by dissolving clots obstructing blood flow to the heart. This helps restore blood supply to the heart muscle, reducing the risk of heart damage and improving survival rates.
- Pulmonary Embolism (PE): It is used in the management of acute pulmonary embolism, where it helps to dissolve the blood clot blocking pulmonary arteries, allowing normal blood flow to the lungs.
- Deep Vein Thrombosis (DVT): Streptokinase may be used in some cases of deep vein thrombosis to break down the clot and prevent further complications.
- Acute Ischemic Stroke: In some cases, Streptokinase can be used to treat acute ischemic stroke by dissolving the clot obstructing blood flow in the brain, although its use in stroke is more limited due to bleeding risks.
There are several contraindications for the use of Streptokinase:
- Active Bleeding: Streptokinase is contraindicated in patients with active bleeding disorders or internal bleeding, including gastrointestinal bleeding or intracranial hemorrhage.
- Recent Surgery or Trauma: It should not be used in patients who have had recent surgical procedures or experienced major trauma (especially within the past 6 weeks), as the risk of bleeding complications is significantly increased.
- History of Hemorrhagic Stroke: Patients with a history of hemorrhagic stroke (brain bleeding) should not receive Streptokinase due to the risk of re-bleeding.
- Severe Liver or Renal Disease: Patients with severe liver disease or renal failure may have an increased risk of bleeding when using Streptokinase.
- Severe Uncontrolled Hypertension: If the patient has severe uncontrolled hypertension (high blood pressure), it should be corrected before using Streptokinase as it can exacerbate bleeding risks.
Common side effects of Streptokinase include:
- Bleeding: The most common and serious side effect is bleeding, which can be internal (e.g., gastrointestinal or intracranial) or external (e.g., bruising, bleeding gums). Careful monitoring of blood counts and clotting parameters is essential.
- Hypotension: Some patients may experience low blood pressure (hypotension) as a result of Streptokinase’s blood-thinning effects.
- Allergic Reactions: Allergic reactions, such as rash, fever, and chills, may occur, particularly in patients with prior exposure to Streptokinase.
- Anaphylaxis: Although rare, Streptokinase may trigger anaphylactic reactions, which can cause difficulty breathing, swelling, or shock. Immediate medical attention is required in such cases.
- Fever: Some patients may develop fever as a reaction to the medication, which typically resolves after discontinuation.
- Nausea and Vomiting: Gastrointestinal upset, including nausea and vomiting, is occasionally seen in some patients.
Severe side effects include:
- Intracranial Hemorrhage: A life-threatening complication of Streptokinase use is intracranial hemorrhage, particularly in patients with prior stroke or uncontrolled hypertension.
- Severe Bleeding: This can manifest as massive gastrointestinal bleeding, pulmonary bleeding, or other forms of internal bleeding. Immediate medical intervention may be required to manage bleeding.
3
Streptokinase works by activating plasminogen, a precursor enzyme in the blood that is converted into plasmin. Plasmin is the active enzyme responsible for breaking down fibrin, the protein that forms blood clots. Streptokinase promotes the formation of plasmin, which dissolves blood clots and helps restore normal blood flow to the affected tissues. This mechanism makes Streptokinase effective in conditions like acute myocardial infarction, pulmonary embolism, and deep vein thrombosis.
However, Streptokinase is non-specific, meaning it can activate plasminogen systemically, leading to clot breakdown not only at the site of the obstruction but throughout the body, which increases the risk of systemic bleeding.
Streptokinase can interact with several medications and substances, potentially altering its effectiveness or safety. These include:
- Anticoagulants: Concomitant use of anticoagulants (e.g., warfarin, heparin) with Streptokinase can increase the risk of excessive bleeding. Careful monitoring of clotting parameters is necessary.
- Antiplatelet Drugs: Drugs such as aspirin or clopidogrel can increase bleeding risk when used with Streptokinase. If both therapies are necessary, proper monitoring is required.
- NSAIDs: Nonsteroidal anti-inflammatory drugs (e.g., ibuprofen, naproxen) can also increase the risk of bleeding. Their use should be carefully monitored in patients receiving Streptokinase.
- Fibrinolytic Agents: Concomitant use of other thrombolytic or fibrinolytic agents (e.g., tPA) should generally be avoided as the risk of bleeding complications may be significantly elevated.
- Blood Pressure Medications: In patients receiving blood pressure-lowering medications, particularly ACE inhibitors or angiotensin II receptor blockers (ARBs), blood pressure should be carefully monitored when using Streptokinase.
The dosing of Streptokinase depends on the condition being treated:
- Acute Myocardial Infarction (MI): The standard dose for acute STEMI is typically 1.5 million units, administered intravenously over 30 to 60 minutes.
- Pulmonary Embolism: For acute pulmonary embolism, the dose is generally 250,000 units initially, followed by 100,000 units per hour for the next 12 hours.
- Deep Vein Thrombosis (DVT): The usual dose for DVT is 250,000 units initially, with a continuous infusion of 100,000 units per hour.
- Acute Ischemic Stroke: For acute ischemic stroke, the use of Streptokinase is more limited, but if used, it is typically 1.5 million units administered intravenously over 60 minutes.
Streptokinase is not typically used in children, as there are limited studies supporting its safety and efficacy in pediatric populations. If used, dosing should be adjusted according to the child's weight and condition. Pediatric dosing would need to be decided by a healthcare provider based on the specific condition being treated and the individual patient's health status.
---
Always consult your healthcare provider before starting Streptokinase to ensure it is appropriate for your condition and to discuss any potential risks, side effects, and interactions based on your individual health profile.
For patients with renal impairment, Streptokinase dosage may need adjustment due to altered drug clearance. Renal failure increases the risk of bleeding, so monitoring of renal function and bleeding parameters is critical. Specific dosing adjustments should be made by a healthcare professional based on individual patient assessment.
Not available in a medicine form yet